Global Injectable drug delivery market is expected to reach USD 797.2 billion by 2022

The global self-injections market is segmented based on product type, dosage form, therapeutic application, route of administration, end-user, distribution channel, and geography.
On the basis of product type the market is segmented into devices and formulations. Devices market is segmented into needle-free injectors, auto injectors, pen injectors, wearable injectors, and other devices and formulations market is segmented into conventional drug delivery formulations, novel drug delivery formulations, and long-acting formulations.
Request for sample pages http://databridgemarketresearch.com/self-injections-market-poised-grow-22-6/
On the basis of usage pattern the global injectable drug delivery market is segmented into curative care, immunization and, others. In 2016, the curative care is expected to dominate the market with 93.2% market share and is expected to grow at a CAGR of 13.1% in the forecast period.
Based on mode of administration the market is segmented into skin, circulatory, organs and central nervous system. Administration through skin is the most common and the highest growing segment with 13.7% CAGR in the forecast period 2016 to 2022.
Based on end-user the global Injectable drug delivery market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies. Among these, in 2016 hospitals dominate the market and the trend is expected to remain the same till 2022.
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2015, North America is expected to account for the largest share of 47.3% of this market, followed by Europe. However, Asia is expected to register the highest CAGR of 14.2% during the forecast period.
Read more: http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/
The report also includes company share analysis for the major companies operating in this market by major regions North America, Europe and Asia Pacific. The details of mergers & acquisitions, product launches, expansions, and product life cycle matrix is also a part of this report. Some of the major players operating in the global Injectable drug delivery market are Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd. among others.